Author

Jonathan C. Javitt

Columbia UniversityORCID 0000-0003-2371-1609Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:rat· 1

Frequent Co-Authors

Daniel C. JavittiD· 1 shared Michael J. ManyakiD· 1 shared Michael T. SapkoiD· 1 shared Riccardo Panicucci· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Daniel C. JavittORCID

Author profile →

2 papers

Recent·Most cited

MicrobiologyAntibioticsPeer-reviewedMar 28, 2024

NRX-101 (D-Cycloserine + Lurasidone) , a Qualified Infectious Disease Product, is Active Against Drug-Resistant Urinary Pathogens In Vitro

Michael T. Sapko, Michael J. Manyak, Riccardo Panicucci, Jonathan C. Javitt

This study evaluates NRX-101, a combination of D-Cycloserine and lurasidone, against drug-resistant urinary pathogens in vitro, showing DCS's antibacterial activity and lurasidone's lack of interference.

2 citations

experimental assay

𝕏 PostBluesky

NeurosciencebioRxivPreprintAug 12, 2022

D-cycloserine, a mixed NMDAR agonist/antagonist is Not Susceptible to Self-administration, unlike S-ketamine Using an Intravenous Self-administration Model in Naive and Ketamine-habituated Sprague-Dawley Rats

Daniel C. Javitt, Jonathan C. Javitt

This study evaluates the abuse liability of D-cycloserine by testing its self-administration in rats, finding it does not lead to self-infusion unlike ketamine.

DOI 10.1101/2022.08.12.503713

ratexperimental assay

𝕏 PostBluesky